← Eichor
Study identifier: NCT07122947 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF

Condition: Atrial Fibrillation  ·  Sponsor: The Cleveland Clinic

PhaseN/A
Planned participants75
Who can joinAll sexes, 22 Years to no upper limit
Healthy volunteersNo

About this study

This is a prospective multicenter clinical study comparing the efficacy of the Apple Watch AFib History tool to the iRhythm Zio Patch monitoring device in quantifying atrial fibrillation (AF) burden after surgical ablation. Patients with AF and mitral valve (MV) disease who undergo a Cox-Maze IV procedure concomitant to MV surgery will be evaluated at serial timepoints for up to 1 year postoperatively. The trial will be conducted in the United States at the Cleveland Clinic in Cleveland, OH and at the Washington University School of Medicine in St. Louis, MO.

This description comes directly from the study's public registry record.

Talk to the study team

Nadia Bakir, MD  ·  216-312-4443  ·  bakirn@ccf.org

Always discuss trial participation with your own doctor first.

Locations (2)

Washington University School of Medicine in St. LouisSt Louis, Missouri, United StatesRecruiting
Cleveland ClinicCleveland, Ohio, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07122947